Supriya Lifescience CFO plans Rs 350 cr capex, targets Rs 2,000 cr revenue by FY29, says learning from Gen Z key to future finance

Read post on cfo.economictimes.indiatimes.com

Can Supriya Lifescience hit Rs 1,000 crore revenue by FY27 and Rs 2,000 crore by FY29 on the back of a Rs 350 crore Capex plan? CFO Krishna Raghunathan tells ETCFO how R&D, automation, and even learning from Gen Z will shape the company’s growth path.